How to Take HCG With TRT: Dosing, Timing, and Injection

Most men on testosterone replacement therapy who add HCG use between 250 and 500 IU injected subcutaneously every other day or two to three times per week. The goal is to mimic the natural signal that keeps the testes active while exogenous testosterone suppresses the body’s own production. Getting the dose, frequency, and injection technique right matters more than it might seem, because HCG’s effects on testicular tissue are sensitive to both how much you use and how often you use it.

Why HCG Matters When You’re on TRT

When you inject testosterone, your brain detects the rising blood levels and responds by dialing down its own signaling hormones, LH and FSH. In men receiving testosterone injections, LH and FSH can become undetectable within two to six weeks depending on the dose.¹ Without LH, Leydig cells in the testes essentially go dormant. They stop producing testosterone locally, and the testes gradually shrink. Over time, sperm production declines or stops altogether.

HCG is structurally similar enough to LH that it activates the same receptors on Leydig cells. By injecting HCG alongside TRT, you provide an artificial LH-like signal that keeps the testes functioning even though the brain has stopped sending its own. This preserves intratesticular testosterone (the concentration of testosterone inside the testes, which is roughly 80 to 100 times higher than what circulates in blood), maintains testicular size, and supports sperm production.

Dosing Based on the Research

The most cited dose-response study on HCG during TRT randomized healthy men to receive testosterone enanthate plus either placebo or HCG at 125, 250, or 500 IU every other day for three weeks. In the placebo group, intratesticular testosterone plummeted by 94%. The 125 IU dose recovered intratesticular testosterone to about 75% of baseline. At 250 IU, it reached roughly 93% of baseline. And 500 IU actually pushed intratesticular testosterone 26% above baseline.²

This study is the foundation for the commonly recommended range of 250 to 500 IU every other day. In practice, many clinicians prescribe 250 IU three times per week or 500 IU twice per week to simplify the schedule while staying in the effective range. The exact choice often depends on individual goals. If preserving fertility is the priority, doses at the higher end may be preferred. If testicular size and general well-being are the main concerns, the lower end tends to be sufficient without unnecessary side effects.

Some protocols use higher doses, such as 750 IU twice weekly. A pilot study of men on continuous testosterone therapy combined HCG at 750 IU subcutaneously twice per week with recombinant FSH and found that sperm counts improved or resumed during treatment, with several men achieving natural pregnancies.³ That protocol added FSH on top of HCG, though, so the higher HCG dose alone doesn’t explain the results. Still, it shows that doses above 500 IU are used in certain clinical contexts, particularly when fertility rescue is urgent.

Why Frequent Small Doses Work Better Than Large Infrequent Ones

There’s a real temptation to simplify HCG dosing by taking one large shot once a week instead of smaller injections multiple times a week. The problem is that Leydig cells are prone to desensitization when hit with too much stimulation at once. A study comparing a single 1,500 IU injection to the same total dose spread across five daily 300 IU injections found striking differences. The single large dose spiked testosterone to about twice baseline within 48 hours, but then testosterone crashed to below normal by day seven. The divided-dose approach produced a steadier testosterone rise without the subsequent crash.⁴

The underlying mechanism is that Leydig cells exposed to large bursts of HCG downregulate their internal signaling machinery. Research on Leydig cell cultures has shown that HCG triggers a dose-dependent and time-dependent decrease in the cell’s ability to produce the signaling molecule cAMP, with maximal desensitization reaching about 90% even from partial prior stimulation.⁵ In plain terms, a huge single dose overwhelms the receptor, and the cell protects itself by becoming temporarily deaf to the signal. Smaller, more frequent doses keep the signal constant without triggering that protective shutdown.

This is why most experienced clinicians avoid weekly HCG dosing at large amounts. The every-other-day or three-times-weekly schedule aligns with HCG’s pharmacokinetics and avoids the boom-and-bust pattern that leads to desensitization and unstable hormone levels.

Subcutaneous Versus Intramuscular Injection

HCG can be injected either into muscle (intramuscular, or IM) or into the fat layer just under the skin (subcutaneous, or SC). Both routes work, but they behave differently in terms of how quickly HCG enters the bloodstream and how long it stays there. Compared to IM injection, SC injection produces a lower and delayed peak in blood HCG levels but a longer half-life, meaning the drug sticks around longer.⁶ The peak concentration and total drug exposure (AUC) are measurably higher with IM injection.⁷

Despite those pharmacokinetic differences, the downstream hormonal effects appear to be essentially the same. The same study that documented delayed SC peaks found that testosterone, LH, and FSH responses were identical between the two routes.⁶ This is likely because HCG’s longer half-life when injected subcutaneously compensates for the lower peak level, ultimately delivering the same total signal to Leydig cells.

In practice, almost everyone on TRT who adds HCG opts for subcutaneous injection. The doses involved are tiny, typically under half a milliliter, and SC injection with a short insulin needle is far less painful and more convenient than IM injection with a longer needle. The most common injection sites are the lower abdomen (a couple of inches to the side of the navel) and the upper thigh. You pinch a small fold of skin, insert the needle at roughly a 45-degree angle, inject slowly, and release. Rotating injection sites prevents scar tissue buildup and local irritation.

One variable that gets less attention is body composition. Research has shown that both peak levels and total absorption of HCG differ between lean and obese individuals regardless of injection route.⁷ If you carry more body fat, particularly around your injection site, it may affect how much HCG reaches your bloodstream and how quickly. This doesn’t mean you need to change your dose, but it’s worth mentioning to your prescribing clinician if blood work suggests the expected effects aren’t materializing.

Fertility Preservation During TRT

Fertility is one of the primary reasons HCG gets added to TRT protocols. Testosterone replacement alone effectively acts as a male contraceptive for many men, and the longer someone stays on TRT without HCG, the more difficult recovery of sperm production becomes. Adding HCG from the start is a different story. In a study following men on concurrent TRT and HCG, no patient became azoospermic (completely lacking sperm) during treatment. Nine of 26 men contributed to pregnancy with their partner during the follow-up period.⁸

It’s worth being honest about the limitations here: HCG helps maintain sperm production, but it doesn’t guarantee it at levels that ensure fertility in every man. FSH, the other pituitary hormone lost during TRT, plays a separate role in sperm maturation that HCG alone doesn’t fully replicate. The pilot study described earlier that combined HCG with recombinant FSH achieved better semen results than HCG alone typically produces.³ For men where fathering a child is an active goal rather than a theoretical future concern, a semen analysis while on the protocol is the only way to know where you stand.

HCG’s role in maintaining fertility is also why some clinicians recommend it be part of a TRT protocol from day one rather than added later. Leydig cells and Sertoli cells that have been dormant for months or years may not respond as robustly as cells that were kept active all along. There is no hard cutoff, but the general principle in clinical practice is that earlier is better for preserving the testicular machinery you want to keep working.⁹

Managing the Estrogen Rise

HCG doesn’t just stimulate testosterone production in the testes. It also stimulates the aromatase enzyme present in Leydig cells, which converts some of that testosterone into estradiol. One study found that estradiol levels surged by about 168% within 24 hours of a single HCG injection.¹⁰ This is a meaningful consideration for men already on TRT, since exogenous testosterone itself gets aromatized in fat tissue. Adding HCG creates a second source of estradiol production, and the combined effect can push estrogen levels high enough to cause symptoms like water retention, mood changes, or breast tissue sensitivity.

This doesn’t mean every man on HCG plus TRT will have estrogen problems. Many do fine, especially at the lower end of HCG dosing. But it does mean estradiol should be monitored via blood work, particularly in the first few months after adding HCG. If estrogen climbs too high, the standard clinical response is to either lower the HCG dose or, in some cases, add a low-dose aromatase inhibitor. Lowering the HCG dose is generally preferred because aromatase inhibitors carry their own side effects and don’t discriminate between testicular and peripheral estrogen production.

Men who are leaner tend to have less aromatase activity in peripheral tissue, so their total estrogen load from HCG may be more manageable. Men with higher body fat are more susceptible to the estrogen spike. This is another reason individual monitoring matters more than following a generic protocol.

Practical Injection Tips

HCG typically comes as a lyophilized powder that you reconstitute with bacteriostatic water. The concentration you mix determines how much liquid you inject per dose. A common preparation is 5,000 IU of HCG reconstituted with 5 mL of bacteriostatic water, giving a concentration of 1,000 IU per mL. At that concentration, a 250 IU dose would be 0.25 mL (or 25 units on an insulin syringe), and a 500 IU dose would be 0.5 mL. Some people prefer a more concentrated mix, such as 5,000 IU in 2.5 mL, so they inject even smaller volumes.

Once reconstituted, HCG should be refrigerated and used within roughly 30 to 60 days, depending on the manufacturer’s guidance. Bacteriostatic water contains a preservative that helps prevent bacterial growth, but the peptide itself gradually degrades at room temperature. Never freeze reconstituted HCG, and discard any vial that appears cloudy or has been sitting at room temperature for extended periods.

For the injection itself:

Needle choice: An insulin syringe with a 29 or 31 gauge needle, half-inch length, is standard for subcutaneous HCG injection. These are widely available at pharmacies.
Site rotation: Alternate between left and right lower abdomen, or rotate among abdomen and upper thigh sites. Repeated injection in the same spot can cause small lumps of scar tissue over time.
Timing of day: There is no strong evidence that morning versus evening injection matters for HCG. Pick a consistent time that works with your schedule.
Coordination with TRT shots: Many men inject HCG on different days from their testosterone to spread out injection days. For instance, someone injecting testosterone on Monday and Thursday might inject HCG on Tuesday, Thursday, and Saturday. Others prefer to consolidate and inject HCG on the same days as testosterone. Neither approach has a clear advantage in terms of hormonal outcomes.

Sourcing HCG After the Regulatory Shift

If you’ve tried to fill an HCG prescription recently and run into difficulty, you’re not imagining things. In March 2020, changes to US federal law reclassified HCG, along with FSH and LH, as biological products. This meant that compounding pharmacies could no longer produce and distribute HCG across state lines unless they obtained a Biologics License Application, a costly and burdensome regulatory requirement.¹¹ Before this change, compounded HCG was widely available and affordable. Afterward, supply became significantly tighter, and patients who had been paying modest prices for compounded HCG found themselves facing either pharmaceutical-grade products at much higher cost or gaps in availability altogether.¹²

The practical fallout has been substantial. Some men switched to pharmaceutical-grade HCG products like Pregnyl or Novarel, which remain available but at higher prices. Others turned to compounding pharmacies that operate within a single state (where different rules apply) or to telehealth clinics that have worked out specific supply arrangements. A small number of men have tried alternative approaches like clomiphene or enclomiphene to maintain testicular function, though these work through a completely different mechanism and aren’t a direct HCG substitute.

If you’re starting TRT and want HCG as part of your protocol, it’s worth confirming your clinic or pharmacy can actually source it before you commit to a plan that depends on it. The regulatory landscape has been evolving, and access varies considerably by state and provider.

Testicular Volume and the Aesthetic Concern

Plenty of men adding HCG to TRT aren’t primarily worried about fertility. They notice their testes shrinking on testosterone alone and want to prevent that. This is a legitimate and common reason for HCG use, and the mechanism is straightforward: without LH stimulation, the Leydig and Sertoli cells that make up much of the testicular mass lose volume. HCG keeps those cells active and plump.

Data from a different clinical context helps illustrate how meaningful this effect is. In a study comparing testosterone therapy to HCG therapy in young men with hypogonadotropic hypogonadism, mean testicular volume was roughly 3.4 mL in those treated with testosterone alone versus 8.3 mL in those treated with HCG.¹³ That study examined a different population (adolescents with a congenital hormone deficiency rather than adult men on TRT), so the numbers aren’t directly transferable, but the direction of the effect is clear. HCG preserves testicular tissue in a way that exogenous testosterone alone does not.

For men on TRT who have already experienced some testicular shrinkage before starting HCG, partial recovery is typical. Full restoration to pre-TRT size is possible but not guaranteed, especially if the testes were unsupported for an extended period. Anecdotally, most men notice a visible difference within four to six weeks of starting HCG, though the degree of regrowth varies.

Beyond Testosterone and Sperm

One underappreciated aspect of HCG use is that it doesn’t just stimulate testosterone production. The Leydig cell produces a range of steroid hormones when activated. HCG stimulation increases the conversion of precursor steroids through the steroidogenic pathway, driving production of pregnenolone and progesterone intermediates in addition to testosterone.¹⁴ Some of these intermediates serve as precursors to neurosteroids, compounds that influence mood, sleep, and cognitive function through activity at receptors in the brain.

This might partly explain why some men report feeling subjectively better on TRT plus HCG than on TRT alone, even when their serum testosterone levels are similar in both scenarios. It’s an area where anecdotal reports run well ahead of controlled research, but the biochemistry supports the plausibility: shutting down testicular steroidogenesis entirely with TRT removes not just intratesticular testosterone but also the suite of other hormones and neurosteroid precursors that Leydig cells produce. HCG keeps that broader production active.

A study of HCG monotherapy in men with hypogonadal symptoms found that 80% of patients reported improvement in low libido and 86% reported improvement in erectile dysfunction during treatment, though all patients with erectile dysfunction were also on another therapy for that condition specifically.¹⁵ Those numbers come from a monotherapy context rather than a combination protocol, so they can’t be directly mapped onto the TRT-plus-HCG experience. But they do suggest that HCG’s effects on well-being extend beyond simply raising a testosterone number on a lab report.